Administration of a Selective Β2 Adrenergic Receptor Antagonist Exacerbates Neuropathology and Cognitive Deficits in a Mouse Model of Alzheimer's Disease
Neurobiology of Aging - United States
doi 10.1016/j.neurobiolaging.2014.06.011
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2014
Authors
Publisher
Elsevier BV